Report Detail

Request for Sample of this report

Pharma & Healthcare COVID-19 Impact on Global Nuclear Medicine/Radiopharmaceutic, Market Insights and Forecast to 2026

  • RnM4075461
    • |
  • 24 June, 2020
    • |
  • Global
    • |
  • 115 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

Nuclear Medicine/Radiopharmaceutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Medicine/Radiopharmaceutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Nuclear Medicine/Radiopharmaceutic market is segmented into
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other

Segment by Application, the Nuclear Medicine/Radiopharmaceutic market is segmented into
Diagnostic
Therapeutic

Regional and Country-level Analysis
The Nuclear Medicine/Radiopharmaceutic market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nuclear Medicine/Radiopharmaceutic market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nuclear Medicine/Radiopharmaceutic Market Share Analysis
Nuclear Medicine/Radiopharmaceutic market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nuclear Medicine/Radiopharmaceutic business, the date to enter into the Nuclear Medicine/Radiopharmaceutic market, Nuclear Medicine/Radiopharmaceutic product introduction, recent developments, etc.
The major vendors covered:
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Jubilant Pharma
Nordion
Eli Lilly
SIEMENS
China Isotope & Radiation
Yantai Dongcheng Biochemicals


1 Study Coverage

  • 1.1 Nuclear Medicine/Radiopharmaceutic Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Nuclear Medicine/Radiopharmaceutic Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Type
    • 1.4.2 Tc-99
    • 1.4.3 I-123/131
    • 1.4.4 In-111
    • 1.4.5 Xe-133
    • 1.4.6 Th-201
    • 1.4.7 Ga-67
    • 1.4.8 Other
  • 1.5 Market by Application
    • 1.5.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Application
    • 1.5.2 Diagnostic
    • 1.5.3 Therapeutic
  • 1.6 Coronavirus Disease 2019 (Covid-19): Nuclear Medicine/Radiopharmaceutic Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Nuclear Medicine/Radiopharmaceutic Industry
      • 1.6.1.1 Nuclear Medicine/Radiopharmaceutic Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Nuclear Medicine/Radiopharmaceutic Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Nuclear Medicine/Radiopharmaceutic Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Estimates and Forecasts
    • 2.1.1 Global Nuclear Medicine/Radiopharmaceutic Revenue 2015-2026
    • 2.1.2 Global Nuclear Medicine/Radiopharmaceutic Sales 2015-2026
  • 2.2 Nuclear Medicine/Radiopharmaceutic Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Nuclear Medicine/Radiopharmaceutic Competitor Landscape by Players

  • 3.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers
    • 3.1.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers (2015-2020)
    • 3.1.2 Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers
    • 3.2.1 Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2015-2020)
    • 3.2.2 Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Nuclear Medicine/Radiopharmaceutic Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Nuclear Medicine/Radiopharmaceutic Revenue in 2019
    • 3.2.5 Global Nuclear Medicine/Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Nuclear Medicine/Radiopharmaceutic Price by Manufacturers
  • 3.4 Nuclear Medicine/Radiopharmaceutic Manufacturing Base Distribution, Product Types
    • 3.4.1 Nuclear Medicine/Radiopharmaceutic Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
    • 3.4.3 Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size by Type (2015-2020)
    • 4.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2020)
    • 4.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Type (2015-2020)
    • 4.1.3 Nuclear Medicine/Radiopharmaceutic Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Type (2021-2026)
    • 4.2.3 Nuclear Medicine/Radiopharmaceutic Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Nuclear Medicine/Radiopharmaceutic Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Nuclear Medicine/Radiopharmaceutic Market Size by Application (2015-2020)
    • 5.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Application (2015-2020)
    • 5.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Application (2015-2020)
    • 5.1.3 Nuclear Medicine/Radiopharmaceutic Price by Application (2015-2020)
  • 5.2 Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Nuclear Medicine/Radiopharmaceutic Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Nuclear Medicine/Radiopharmaceutic by Country
    • 6.1.1 North America Nuclear Medicine/Radiopharmaceutic Sales by Country
    • 6.1.2 North America Nuclear Medicine/Radiopharmaceutic Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Type
  • 6.3 North America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Nuclear Medicine/Radiopharmaceutic by Country
    • 7.1.1 Europe Nuclear Medicine/Radiopharmaceutic Sales by Country
    • 7.1.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Type
  • 7.3 Europe Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic by Region
    • 8.1.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Region
    • 8.1.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Type
  • 8.3 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Nuclear Medicine/Radiopharmaceutic by Country
    • 9.1.1 Latin America Nuclear Medicine/Radiopharmaceutic Sales by Country
    • 9.1.2 Latin America Nuclear Medicine/Radiopharmaceutic Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Type
  • 9.3 Central & South America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic by Country
    • 10.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Country
    • 10.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Type
  • 10.3 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Application

11 Company Profiles

  • 11.1 GE Healthcare
    • 11.1.1 GE Healthcare Corporation Information
    • 11.1.2 GE Healthcare Description, Business Overview and Total Revenue
    • 11.1.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Products Offered
    • 11.1.5 GE Healthcare Recent Development
  • 11.2 Bracco Imaging
    • 11.2.1 Bracco Imaging Corporation Information
    • 11.2.2 Bracco Imaging Description, Business Overview and Total Revenue
    • 11.2.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Products Offered
    • 11.2.5 Bracco Imaging Recent Development
  • 11.3 Mallinckrodt
    • 11.3.1 Mallinckrodt Corporation Information
    • 11.3.2 Mallinckrodt Description, Business Overview and Total Revenue
    • 11.3.3 Mallinckrodt Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Products Offered
    • 11.3.5 Mallinckrodt Recent Development
  • 11.4 Lantheus Medical Imaging
    • 11.4.1 Lantheus Medical Imaging Corporation Information
    • 11.4.2 Lantheus Medical Imaging Description, Business Overview and Total Revenue
    • 11.4.3 Lantheus Medical Imaging Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Products Offered
    • 11.4.5 Lantheus Medical Imaging Recent Development
  • 11.5 Bayer
    • 11.5.1 Bayer Corporation Information
    • 11.5.2 Bayer Description, Business Overview and Total Revenue
    • 11.5.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Bayer Nuclear Medicine/Radiopharmaceutic Products Offered
    • 11.5.5 Bayer Recent Development
  • 11.6 Jubilant Pharma
    • 11.6.1 Jubilant Pharma Corporation Information
    • 11.6.2 Jubilant Pharma Description, Business Overview and Total Revenue
    • 11.6.3 Jubilant Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Products Offered
    • 11.6.5 Jubilant Pharma Recent Development
  • 11.7 Nordion
    • 11.7.1 Nordion Corporation Information
    • 11.7.2 Nordion Description, Business Overview and Total Revenue
    • 11.7.3 Nordion Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Nordion Nuclear Medicine/Radiopharmaceutic Products Offered
    • 11.7.5 Nordion Recent Development
  • 11.8 Eli Lilly
    • 11.8.1 Eli Lilly Corporation Information
    • 11.8.2 Eli Lilly Description, Business Overview and Total Revenue
    • 11.8.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Eli Lilly Nuclear Medicine/Radiopharmaceutic Products Offered
    • 11.8.5 Eli Lilly Recent Development
  • 11.9 SIEMENS
    • 11.9.1 SIEMENS Corporation Information
    • 11.9.2 SIEMENS Description, Business Overview and Total Revenue
    • 11.9.3 SIEMENS Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 SIEMENS Nuclear Medicine/Radiopharmaceutic Products Offered
    • 11.9.5 SIEMENS Recent Development
  • 11.10 China Isotope & Radiation
    • 11.10.1 China Isotope & Radiation Corporation Information
    • 11.10.2 China Isotope & Radiation Description, Business Overview and Total Revenue
    • 11.10.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Products Offered
    • 11.10.5 China Isotope & Radiation Recent Development
  • 11.1 GE Healthcare
    • 11.1.1 GE Healthcare Corporation Information
    • 11.1.2 GE Healthcare Description, Business Overview and Total Revenue
    • 11.1.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Products Offered
    • 11.1.5 GE Healthcare Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Nuclear Medicine/Radiopharmaceutic Market Estimates and Projections by Region
    • 12.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Regions 2021-2026
  • 12.2 North America Nuclear Medicine/Radiopharmaceutic Market Size Forecast (2021-2026)
    • 12.2.1 North America: Nuclear Medicine/Radiopharmaceutic Sales Forecast (2021-2026)
    • 12.2.2 North America: Nuclear Medicine/Radiopharmaceutic Revenue Forecast (2021-2026)
    • 12.2.3 North America: Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Nuclear Medicine/Radiopharmaceutic Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Nuclear Medicine/Radiopharmaceutic Sales Forecast (2021-2026)
    • 12.3.2 Europe: Nuclear Medicine/Radiopharmaceutic Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Nuclear Medicine/Radiopharmaceutic Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Nuclear Medicine/Radiopharmaceutic Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Nuclear Medicine/Radiopharmaceutic Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Nuclear Medicine/Radiopharmaceutic Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Nuclear Medicine/Radiopharmaceutic Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Nuclear Medicine/Radiopharmaceutic Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Nuclear Medicine/Radiopharmaceutic Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Nuclear Medicine/Radiopharmaceutic Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Nuclear Medicine/Radiopharmaceutic Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Nuclear Medicine/Radiopharmaceutic. Industry analysis & Market Report on COVID-19 Impact on Global Nuclear Medicine/Radiopharmaceutic is a syndicated market report, published as COVID-19 Impact on Global Nuclear Medicine/Radiopharmaceutic, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Nuclear Medicine/Radiopharmaceutic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,900.00
    		$5,850.00
    		$7,800.00
    		3,108.30
    		4,662.45
    		6,216.60
    		3,623.10
    		5,434.65
    		7,246.20
    		596,427.00
    		894,640.50
    		1,192,854.00
    		325,338.00
    		488,007.00
    		650,676.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo